LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Avadel Pharmaceuticals (NASDAQ: AVDL)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ AVDL Avadel Pharmaceuticals
Palczuk Linda / director
01/21/2025
Buy
$7.93
5,000
$40K
67,900
NASDAQ AVDL Avadel Pharmaceuticals
Thornton Peter J. / director
01/13/2025
Buy
$8.05
10,000
$80K
104,055
NASDAQ AVDL Avadel Pharmaceuticals
Ende Eric J / director
01/13/2025
Buy
$7.84
30,000
$235K
208,900
NASDAQ AVDL Avadel Pharmaceuticals
Palczuk Linda / director
12/17/2024
Buy
$10.93
25,000
$273K
25,000
NASDAQ AVDL Avadel Pharmaceuticals
MCHUGH THOMAS S / officer: Chief Financial Officer
12/13/2024
Buy
$10.44
2,300
$24K
87,800
NASDAQ AVDL Avadel Pharmaceuticals
MCHUGH THOMAS S / officer: Chief Financial Officer
12/11/2024
Buy
$10.49
5,000
$52K
85,500
NASDAQ AVDL Avadel Pharmaceuticals
Divis Gregory J / director, officer: Chief Executive Officer
12/09/2024
Buy
$9.82
402
$4K
10,000
NASDAQ AVDL Avadel Pharmaceuticals
Divis Gregory J / director, officer: Chief Executive Officer
12/06/2024
Buy
$9.98
9,598
$96K
9,598
NASDAQ AVDL Avadel Pharmaceuticals
Glass Geoffrey Michael / director
12/10/2024
Buy
$9.80
10,204
$100K
75,904
NASDAQ AVDL Avadel Pharmaceuticals
Glass Geoffrey Michael / director
12/10/2024
Buy
$9.89
10,075
$100K
69,075
NASDAQ AVDL Avadel Pharmaceuticals
Palczuk Linda / director
12/06/2024
Buy
$10.19
3,000
$31K
66,400